Assessing Clinical Outcomes in Alzheimer's Disease Agitation

NCT04797715 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

178

Enrollment

INDUSTRY

Sponsor class

Conditions

Agitation in Patients With Dementia of the Alzheimer's Type
Alzheimer Disease
Agitation,Psychomotor

Interventions

DRUG: AXS-05
DRUG: Placebo

Sponsor

Axsome Therapeutics, Inc.